U.S. Markets open in 4 hrs 4 mins
  • S&P Futures

    4,138.00
    +5.25 (+0.13%)
     
  • Dow Futures

    33,576.00
    +6.00 (+0.02%)
     
  • Nasdaq Futures

    14,004.25
    +28.50 (+0.20%)
     
  • Russell 2000 Futures

    2,229.60
    +4.70 (+0.21%)
     
  • Crude Oil

    61.17
    +0.99 (+1.65%)
     
  • Gold

    1,746.10
    -1.50 (-0.09%)
     
  • Silver

    25.52
    +0.10 (+0.39%)
     
  • EUR/USD

    1.1966
    +0.0011 (+0.0957%)
     
  • 10-Yr Bond

    1.6230
    0.0000 (0.00%)
     
  • Vix

    16.66
    -0.25 (-1.48%)
     
  • GBP/USD

    1.3783
    +0.0031 (+0.2219%)
     
  • USD/JPY

    108.9950
    -0.0530 (-0.0486%)
     
  • BTC-USD

    63,591.45
    +1,132.33 (+1.81%)
     
  • CMC Crypto 200

    1,366.67
    +72.68 (+5.62%)
     
  • FTSE 100

    6,902.82
    +12.33 (+0.18%)
     
  • Nikkei 225

    29,620.99
    -130.62 (-0.44%)
     

Why Sutro, Lumos And More Health Care Stocks Are Moving Today

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
Tanzeel Akhtar
·2 min read
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Sabra Health Care REIT (NASDAQ: SBRA) shares are trading higher on Thursday after JMP Securities upgraded the stock from Market Perform to Market Outperform and announced a price target of $24 per share.

Sabra Health Care REIT Inc is a health care facility real estate investment trust. The company operates one segment that owns and invests in health care real estate.

Sabra Health Care REIT shares were trading up 2.58% at $17.66 at the time of publication on Thursday. The stock has a 52-week high of $22.54 and a 52-week low of $5.54.

Sutro Biopharma (NASDAQ: STRO) shares are trading higher after Stifel initiated coverage on the stock with a Buy rating and a price target of $25 per share.

Sutro Biopharma is a clinical-stage company developing and manufacturing therapeutics. Primarily focused on next generation cancer and autoimmune therapeutics — antibody conjugates, bispecific antibodies and cytokine derivatives.

Sutro Biopharma shares were trading up 2.69% at $16.79. The stock has a 52-week high of $19.18 and a 52-week low of $6.

Enlivex Therapeutics (NASDAQ: ENLV) shares are trading higher after the company reported "positive" interim results of an investigator-initiated Phase II clinical trial evaluating Allocetra in severe COVID-19 patients.

Enlivex Therapeutics is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing allogeneic drug pipeline for rebalancing immune hyper-responses.

Enlivex Therapeutics shares were trading up 43.53% at $11.87. The stock has a 52-week high of $16.94 and a 52-week low of $3.59.

Lumos Pharma (NASDAQ: LUMO) shares are trading higher after Cantor Fitzgerald initiated coverage on the stock with an Overweight rating and a price target of $32 per share.

Lumos Pharma is a biopharmaceutical company that develops treatments for cancer and rare diseases. It carries out both clinical-stage and preclinical research on a range of molecules that help the immune system fight off cancer cells.

Lumos Pharma shares were trading up 6.07% at $16.31. The stock has a 52-week high of $32.40 and a 52-week low of $6.74.

Omega Healthcare Investors (NYSE: OHI) shares are trading higher after JMP Securities upgraded the stock from Market Perform to Market Outperform and announced a price target of $43 per share.

Omega Healthcare Investors is a health care facility real estate investment trust that invests in the United States real estate markets. Omega's portfolio focuses on long-term health care facilities.

Omega Healthcare Investors shares were trading up 2.12% at $37.63. The stock has a 52-week high of $45.22 and a 52-week low of $13.33.

See more from Benzinga

© 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.